The API Surge helped Strong Q1 Performance at RPG Life Sciences during the first quarter of FY27. The company reported healthy revenue growth, stronger domestic formulations, and resumed API operations. It also announced a major restructuring plan...
Strong Business, Indegene, Q1 FY27, operating revenue, net profit, EBITDA, EBITDA margin, active clients, Gen AI, pharmaceutical services, healthcare technology, revenue growth
MedTech Hub development in India accelerates as a new policy framework and global partnerships reshape the country’s medical technology sector
Innovative expansion and drug regulation continue to reshape India’s pharmaceutical sector. The latest updates signify a strong push toward technology-driven research
Patients with Heart Failure often need hospital visits when fluid builds up in the body. MannKind now wants to change that with its Autoinjector Pen technology. The company is developing a treatment that could replace IV infusions with a quick...
AI partnerships now drive a major shift in how global drug makers build and scale innovation pipelines, traditional drug discovery can take over a decade and cost billions, with high failure rates in clinical trials
Biocon has secured a major regulatory milestone with Health Canada's approval for its Autoinjector Pen version of Yesintek. The approval strengthens the company's biosimilar portfolio in North America.
Ebola Vaccine gains momentum as Merck partners with a global health group to advance manufacturing to clinical supply by 2026
India has detected dengue strains from all four virus serotypes ahead of the dengue vaccine rollout. The finding comes from a nationwide surveillance study. It has raised attention because infection with different serotypes can increase the risk...
Today’s news highlights drug approvals, therapy expansion, and global market growth shaping the pharmaceutical industry